Variations in rates of comorbid substance use in psychosis between mental health settings and geographical areas in the UK

Social Psychiatry and Psychiatric Epidemiology

Volumn 44, Issue 6, 2009, Pages 429-447

  Carrà, Giuseppe ^a   Johnson, Sonia ^a  

^a ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

Author keywords

Population characteristics; Prevalence; Severe mental illness; Substance abuse; United Kingdom

Indexed keywords

ALCOHOL; CANNABIS; METHADONE;

ALCOHOL ABUSE; CANNABIS ADDICTION; COMORBIDITY; CRISIS INTERVENTION; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DRUG DEPENDENCE; DRUG DEPENDENCE TREATMENT; ETHNIC DIFFERENCE; FORENSIC PSYCHIATRY; GEOGRAPHY; HEALTH CARE DELIVERY; HEALTH CARE PLANNING; HOSPITAL PATIENT; HUMAN; MEDICAL LITERATURE; MENTAL HEALTH CARE; PARANOID PSYCHOSIS; PSYCHOSIS; REVIEW; SCHIZOAFFECTIVE PSYCHOSIS; SCHIZOPHRENIA; SOCIAL ASPECT; SUBSTANCE ABUSE; SYSTEMATIC REVIEW; UNITED KINGDOM;

ADULT; AGE DISTRIBUTION; ALCOHOLISM; COMMUNITY MENTAL HEALTH SERVICES; COMORBIDITY; DIAGNOSIS, DUAL (PSYCHIATRY); ETHNIC GROUPS; FEMALE; FORENSIC PSYCHIATRY; GREAT BRITAIN; HUMANS; MALE; MEDLINE; PSYCHOTIC DISORDERS; SUBSTANCE ABUSE TREATMENT CENTERS; SUBSTANCE-RELATED DISORDERS;

EID: 67349244833     PISSN: 09337954     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00127-008-0458-2     Document Type: Review

References (108)

1. Adams CE, Coutinho ESF, Davis J, Duggan L, Leucht S, Li C, Tharyan P (2008) Cochrane Schizophrenia Group. Schizophr Bull 34:259-265
2. Afuwape SA, Johnson S, Craig T, Miles H, Leese M, Thornicroft G (2006) Ethnic differences among a community cohort of individuals with dual diagnosis in South London. Journal of Mental Health 15:551-567
3. American Psychiatric Association (1994) Diagnostic and statistical manual of mental disorders, 4th edn, revised edn. American Psychiatric Association, Washington, DC
4. Barnaby B, Drummond C, McCloud A, Burns T, Omu N (2003) Substance misuse in psychiatric inpatients: Comparison of a screening questionnaire survey with case notes. BMJ 327:783-784
5. Barnes TR, Mutsatsa SH, Hutton SB, Watt HC, Joyce EM (2006) Comorbid substance use and age at onset of schizophrenia. Br J Psychiatry 188:237-242
6. Barnett JH, Werners U, Secher SM, Hill KE, Brazil R, Masson K, Pernet DE, Kirkbride JB, Murray GK, Bullmore ET, Jones PB (2007) Substance use in a population-based clinic sample of people with first-episode psychosis. Br J Psychiatry 190:515-520
7. Bernadt MW, Mumford J, Murray RM (1984) Can accurate drinking histories be obtained from psychiatric patients by a nurse conducting screening interviews? Br J Addict 79:201-206
8. Bernadt MW, Murray RM (1986) Psychiatric disorder, drinking and alcoholism: What are the links? Br J Psychiatry 148:393-400
9. Blane D, Power C, Bartley M (1996) Illness behaviour and the measurement of class differentials in morbidity. J R Stat Soc Ser A Stat Soc 159:77-92
10. Brady K, Casto S, Lydiard RB, Malcolm R, Arana G (1991) Substance abuse in an inpatient psychiatric sample. Am J Drug Alcohol Abuse 17:389-397
11. Brown S (1998) Substance misuse in a chronic psychosis population. Psychiatr Bull R Coll Psychiatr 22:595-598
12. Burns T, Kendrick T (1997) The primary care of patients with schizophrenia: A search for good practice. Br J Gen Pract 47:515-520
13. Cantwell R, Brewin J, Glazebrook C, Dalkin T, Fox R, Medley I, Harrison G (1999) Prevalence of substance misuse in first-episode psychosis. Br J Psychiatry 174:150-153
14. Cleary M, Hunt GE, Matheson SL, Siegfried N, Walter G (2008) Psychosocial interventions for people with both severe mental illness and substance misuse. Cochrane Database Syst Rev 1:ARt. No.:CD001088
15. Clifford P (1993) FACE profile. Research Unit, Royal College of Psychiatrists, London
16. Commander M, Sashidharan S, Rana T, Ratnayake T (2005) North Birmingham assertive outreach evaluation. Patient characteristics and clinical outcomes. Soc Psychiatry Psychiatr Epidemiol 40:988-993
17. Corbett M, Duggan C, Larkin E (1998) Substance misuse and violence: A comparison of special hospital inpatients diagnosed with either schizophrenia or personality disorder. Crim Behav Ment Health 8:311-321
18. Crawford V, Crome IB, Clancy C (2003) Co-existing problems of mental health and substance misuse (dual diagnosis): A literature review. Drugs 10(Suppl 1):1-74
19. Department of Health (1999) National Service Framework for Mental Health. Modern Standards and Service Models for Mental Health. Department of Health, London
20. Department of Health (2002) Mental Health Policy implementation guide: dual diagnosis good practice guide. Department of Health, London
21. Derogatis LR, Melisaratos N (1983) The brief symptom inventory: An introductory report. Psychol Med 13:595-605
22. Dixon L, Haas G, Weiden PJ, Sweeney J, Frances AJ (1991) Drug abuse in schizophrenic patients: Clinical correlates and reasons for use. Am J Psychiatry 148:224-230
23. Drake RE, Alterman AI, Rosenberg SR (1993) Detection of substance use disorders in severely mentally ill patients. Community Ment Health J 29:175-192
24. Drake RE, Mueser KT, McHugo GJ (1996) Clinician rating scales: Alcohol Use Scale (AUS), Drug Use Scale (DUS) and Substance Abuse Treatment Scale (SATS). In: Sederer L, Dickey B (eds) Outcomes assessment in clinical practice. Williams and Wilkins, Baltimore
25. Duke PJ, Pantelis C, Barnes TR (1994) South Westminster schizophrenia survey. Alcohol use and its relationship to symptoms, tardive dyskinesia and illness onset. Br J Psychiatry 164:630-636
26. Duke PJ, Pantelis C, McPhillips MA, Barnes TR (2001) Comorbid non-alcohol substance misuse among people with schizophrenia: epidemiological study in central London. Br J Psychiatry 179:509-513
27. European Monitoring Centre for Drugs and Drug Addiction-EMCDDA (2004) Comorbidity - drug use and mental disorders. Drugs Focus 14:1-4
28. Fakhoury WKH, Priebe S, Study Group PLAO (2006) An unholy alliance: substance abuse and social exclusion among assertive outreach patients. Acta Psychiatr Scand 114:124-131
29. Farrell M, Boys A, Bebbington P, Brugha T, Coid J, Jenkins R, Lewis G, Meltzer H, Marsden J, Singleton N, Taylor C (2002) Psychosis and drug dependence: Results from a national survey of prisoners. Br J Psychiatry 181:393-398
30. Farrell M, Howes S, Taylor C, Lewis G, Jenkins R, Bebbington P, Jarvis M, Brugha T, Gill B, Meltzer H (2003) Substance misuse and psychiatric comorbidity: An overview of the OPCS National Psychiatric Morbidity Survey. Int Rev Psychiatry 15:43-49
31. Fearon P, Kirkbride JB, Morgan C, Dazzan P, Morgan K, Lloyd T, Hutchinson G, Tarrant J, Fung WLA, Holloway J, Mallett R, Harrison G, Leff J, Jones PB, Murray RM (2006) Incidence of schizophrenia and other psychoses in ethnic minority groups: Results from the MRC AESOP Study. Psychol Med 36:1541-1550
32. Fleming MF, Barry KL (1991) A three-sample test of an alcohol screening questionnaire. Alcohol Alcohol 26:81-91
33. Fowler IL, Carr VJ, Carter NT, Lewin TJ (1998) Patterns of current and lifetime substance use in schizophrenia. Schizophr Bull 24:443-455
34. Frisher M, Collins J, Millson D, Crome I, Croft P (2004) Prevalence of comorbid psychiatric illness and substance misuse in primary care in England and Wales. J Epidemiol Community Health 58:1036-1041
35. Frisher M, Hickman M, Kraus L, Mariani F, Wiessing L (2001) A comparison of different methods for estimating the prevalence of problematic drug misuse in Great Britain. Addiction 96:1465-1476
36. Furr-Holden CDM, Anthony JC (2003) Epidemiologic differences in drug dependence: A US-UK cross-national comparison. Soc Psychiatry Psychiatr Epidemiol 38:165-172
37. Gaite L, Vazquez-Barquero JL, Borra C, Ballesteros J, Schene A, Welcher B, Thornicroft G, Becker T, Ruggeri M, Herran A, EPSILON Study Group. (2002) The Epsilon Study Group. Quality of life in patients with schizophrenia in five European countries: The EPSILON study. Acta Psychiatr Scand 105:283-292
38. Ghodse H (2002) Drugs and addictive behaviour. Cambridge University Press, Cambridge
39. Gossop M, Drake S, Griffiths P, Hando J, Powis B, Hall W, Strang J (1995) The Severity of Dependence Scale (SDS): Psychometric properties of the SDS in English and Australian samples of heroin, cocaine and amphetamine users. Addiction 90:607-614
40. Graham HL, Maslin J, Copello A, Birchwood M, Mueser K, McGovern D, Georgiou G (2001) Drug and alcohol problems amongst individuals with severe mental health problems in an inner city area of the UK. Soc Psychiatry Psychiatr Epidemiol 36:448-455
41. Grech A, Takei N, Murray RM (1998) Comparison of cannabis use in psychotic patients and controls in London and Malta. Schizophr Res 29:22
42. Grech A, Takei N, Murray RM (1998) Psychosis and cannabis use. Schizophr Res 29:21
43. Haddock G, Lewis S, Bentall R, Dunn G, Drake R, Tarrier N (2006) Influence of age on outcome of psychological treatments in first-episode psychosis. Br J Psychiatry 188:250-254
44. Havassy BE, Arns PG (1998) Relationship of cocaine and other substance dependence to well-being of high-risk psychiatric patients. Psychiatr Serv 49:935-940
45. Hilton ME, Clark WB (1991) Measuring drinking problems in the 1984 National Alcohol Survey. In: Clark WB, Hilton ME (eds) Alcohol in America. State University of New York, Albany
46. Hunt GE, Bergen J, Bashir M (2002) Medication compliance and comorbid substance abuse in schizophrenia: Impact on community survival 4 years after a relapse. Schizophr Res 54:253-264
47. Iley K, Nazroo J (2001) Ethnic inequalities in mental health: A critical examination of the evidence. In: Culley L, Dyson S (eds) Sociology, ethnicity and nursing practice. Palgrave, Basingstoke, pp 67-89
48. Isaac M, Isaac M, Holloway F (2005) Is cannabis an anti-antipsychotic? The experience in psychiatric intensive care. Hum Psychopharmacol 20:207-210
49. Isherwood S, Brooke D (2001) Prevalence and severity of substance misuse among referrals to a local forensic service. Journal of Forensic Psychiatry 12:446-454
50. Jenkins R, Bebbington P, Brugha T, Farrell M, Gill B, Lewis G, Meltzer H, Petticrew M (1997) The National Psychiatric Morbidity Surveys of Great Britain - strategy and methods. Psychol Med 27:765-774
51. Johnson S (1997) Dual diagnosis of severe mental illness and substance misuse: A case for specialist services? Br J Psychiatry 171:205-208
52. Johnson S, Zinkler M, Priebe S (2001) Mental health service provision in England. Acta Psychiatr Scand Suppl 410:47-55
53. Johnson S, Nolan F, Hoult J, White IR, Bebbington P, Sandor A, McKenzie N, Patel SN, Pilling S (2005) Outcomes of crises before and after introduction of a crisis resolution team. Br J Psychiatry 187:68-75
54. Johnson S, Nolan F, Pilling S, Sandor A, Hoult J, McKenzie N, White IR, Thompson M, Bebbington P (2005) Randomised controlled trial of acute mental health care by a crisis resolution team: The north Islington crisis study. BMJ 331:599-602
55. Johnson S, Thornicroft G, Afuwape S, Leese M, White IR, Hughes E, Wanigaratne S, Miles H, Craig T (2007) Effects of training community staff in interventions for substance misuse in dual diagnosis patients with psychosis (COMO study): Cluster randomised trial. Br J Psychiatry 191:451-452
56. Kavanagh DJ, Waghorn G, Jenner L, Chant DC, Carr V, Evans M, Herrman H, Jablensky A, McGrath JJ (2004) Demographic and clinical correlates of comorbid substance use disorders in psychosis: Multivariate analyses from an epidemiological sample. Schizophr Res 66:115-124
57. Kendler KS, Gallagher TJ, Abelson JM, Kessler RC (1996) Lifetime prevalence, demographic risk factors, and diagnostic validity of nonaffective psychosis as assessed in a US community sample. Arch Gen Psychiatry 53:1022-1031
58. Kessler RC, Nelson CB, McGonagle KA, Edlund MJ, Frank RG, Leaf PJ (1996) The epidemiology of co-occurring addictive and mental disorders: implications for prevention and service utilization. Am J Orthopsychiatry 66:17-31
59. Killaspy H, Bebbington P, Blizard R, Johnson S, Nolan F, Pilling S, King M (2006) The REACT study: Randomised evaluation of assertive community treatment in north London. BMJ 332:815-820
60. Kirkbride JB, Fearon P, Morgan C, Dazzan P, Morgan K, Murray RM, Jones PB (2007) Neighbourhood variation in the incidence of psychotic disorders in Southeast London. Soc Psychiatry Psychiatr Epidemiol 42(6):438-445
61. Lewis S, Tarrier N, Haddock G, Bentall R, Kinderman P, Kingdon D, Siddle R, Drake R, Everitt J, Leadley K, Benn A, Grazebrook K, Haley C, Akhtar S, Davies L, Palmer S, Faragher B, Dunn G (2002) Randomised controlled trial of cognitive-behavioural therapy in early schizophrenia: acute-phase outcomes. Br J Psychiatry 181(Suppl. 43):s91-s97
62. Ley A, Jeffery D, Ruiz J, Mc Laren S, Gillespie C (2002) Underdetection of comorbid drug use at acute psychiatric admission. Psychiatr Bull R Coll Psychiatr 26:248-251
63. Margolese HC, Malchy L, Negrete JC, Tempier R, Gill K (2004) Drug and alcohol use among patients with schizophrenia and related psychoses: Levels and consequences. Schizophr Res 67:157-166
64. Marsden J, Gossop M, Stewart D, Rolfe A, Farrell M (2000) Psychiatric symptoms among clients seeking treatment for drug dependence. Intake data from the National Treatment Outcome Research Study. Br J Psychiatry 176:285-289
65. McCreadie RG, Scottish Comorbidity Study Group (2002) Use of drugs, alcohol and tobacco by people with schizophrenia: Case-control study. Br J Psychiatry 181:321-325
66. McCrone P, Menezes PR, Johnson S, Scott H, Thornicroft G, Marshall J, Bebbington P, Kuipers E (2000) Service use and costs of people with dual diagnosis in South London. Acta Psychiatr Scand 101:464-472
67. McGuffin P, Farmer AE, Harvey I (1991) A polydiagnostic application of operational criteria in studies of psychotic illness: Development and reliability of the OPCRIT system. Arch Gen Psychiatry 48:764-770
68. Menezes PR, Johnson S, Thornicroft G, Marshall J, Prosser D, Bebbington P, Kuipers E (1996) Drug and alcohol problems among individuals with severe mental illness in south London. Br J Psychiatry 168:612-619
69. Mericle AA, Havassy BE (2008) Characteristics of recent violence among entrants to acute mental health and substance abuse services. Soc Psychiatry Psychiatr Epidemiol 43:392-402
70. Miles H, Johnson S, Amponsah-Afuwape S, Finch E, Leese M, Thornicroft G (2003) Characteristics of subgroups of individuals with psychotic illness and a comorbid substance use disorder. Psychiatr Serv 54:554-561
71. Mowbray CT, Ribisl KM, Solomon M, Luke DA, Kewson TP (1997) Characteristics of dual diagnosis patients admitted to an urban, public psychiatric hospital: An examination of individual, social, and community domains. Am J Drug Alcohol Abuse 23:309-326
72. Mueser KT, Bond GR, Drake RE, Resnick SG (1998) Models of community care for severe mental illness: A review of research on case management. Schizophr Bull 24:37-74
73. Mueser KT, Essock SM, Drake RE, Wolfe RS, Frisman L (2001) Rural and urban differences in patients with a dual diagnosis. Schizophr Res 48:93-107
74. Mueser KT, Yarnold PR, Bellack AS (1992) Diagnostic and demographic correlates of substance abuse in schizophrenia and major affective disorder. Acta Psychiatr Scand 85:48-55
75. Mueser KT, Yarnold PR, Levinson DF, Singh H, Bellack AS, Kee K, Morrison RL, Yadalam KG (1990) Prevalence of substance abuse in schizophrenia: demographic and clinical correlates. Schizophr Bull 16:31-56
76. Nazareth I, King M, Haines A, Rangel L, Myers S (1993) Accuracy of diagnosis of psychosis on general practice computer system. BMJ 307:32-34
77. Office for National Statistics (1991) Census, April 1991. ONS, London
78. Office for National Statistics (2001) Census, April 2001. ONS, London
79. Office of the Deputy Prime Minister (2002) Urban and rural area definitions: A user guide. ODPM, London
80. Phillips P, Johnson S (2003) Drug and alcohol misuse among inpatients with psychotic illnesses in three inner-London psychiatric units. Psychiatr Bull R Coll Psychiatr 27:217-220
81. Priebe S, Fakhoury W, Watts J, Bebbington P, Burns T, Johnson S, Muijen M, Ryrie I, White I, Wright C (2003) Assertive outreach teams in London: patient characteristics and outcomes. Pan-London Assertive Outreach Study, part 3. Br J Psychiatry 183:148-154
82. RachBeisel J, Scott J, Dixon L (1999) Co-occurring severe mental illness and substance use disorders: A review of recent research. Psychiatr Serv 50:1427-1434
83. Regier DA, Farmer ME, Rae DS (1990) Co-morbidity of mental disorders with alcohol and other drug abuse. Results from the Epidemiological Catchment Area (ECA) study. JAMA 264:2511-2518
84. Robins LN, Orvaschel H, Antony J, Blazer D, Burman A, Burke J (1985) The diagnostic interview schedule. In: Eaton WW, Kessler LG (eds) Epidemiologic methods in psychiatry: The epidemiological catchment area program. Academic Press, Orlando, pp 143-171
85. Saunders JB, Aasland OG, Babor TF, de la Fuente JR, Grant M (1993) Development of the alcohol use disorders identification test (AUDIT): WHO collaborative project on early detection of persons with harmful alcohol consumption II. Addiction 88:791-804
86. Schofield N, Quinn J, Haddock G, Barrowclough C (2001) Schizophrenia and substance misuse problems: A comparison between patients with and without significant carer contact. Soc Psychiatry Psychiatr Epidemiol 36:523-528
87. Schomerus G, Heider D, Angermeyer MC, Bebbington PE, Azorin JM, Brugha T, Toumi M, European Schizophrenia Cohort (2007) Residential area and social contacts in schizophrenia. Results from the European Schizophrenia Cohort (EuroSC). Soc Psychiatry Psychiatr Epidemiol 42:617-622
88. Scott H, Johnson S, Menezes P, Thornicroft G, Marshall J, Bindman J, Bebbington P, Kuipers E (1998) Substance misuse and risk of aggression and offending among the severely mentally ill. Br J Psychiatry 172:345-350
89. Singleton N, Bumpstead R, O'Brien M, Lee A, Meltzer H (2001) Psychiatric morbidity among adults living in private households, 2000. The Stationery Office, London
90. Skinner HA (1982) The drug misuse test. Addict Behav 7:363-371
91. Smith SM, Stinson FS, Dawson DA, Goldstein R, Huang B, Grant BF (2006) Race/ethnic differences in the prevalence and co-occurrence of substance use disorders and independent mood and anxiety disorders: Results from the National Epidemiologic Survey on Alcohol and Related Conditions. Psychol Med 36:987-998
92. Swartz MS, Wagner HR, Swanson JW, Stroup TS, McEvoy JP, Canive JM, Miller del D, Reimherr F, McGee M, Khan A, Van Dorn R, Rosenheck RA, Lieberman JA (2006) Substance use in persons with schizophrenia: baseline prevalence and correlates from the NIMH CATIE study. J Nerv Ment Dis 194:164-172
93. Taylor PJ, Leese M, Williams D, Butwell M, Daly R, Larkin E (1998) Mental disorder and violence. Br J Psychiatry 172:218-226
94. Urbanoski KA, Cairney J, Adlaf E, Rush B (2007) Substance abuse and quality of life among severely mentally ill consumers: A longitudinal modelling analysis. Soc Psychiatry Psychiatr Epidemiol 42:810-818
95. Van Os J, Castle DJ, Takei N, Der G, Murray RM (1996) Psychotic illness in ethnic minorities: Clarification from the 1991 Census. Psychol Med 26:203-208
96. Virgo N, Bennett G, Higgins D, Bennett L, Thomas P (2001) The prevalence and characteristics of co-occurring serious mental illness (SMI) and substance abuse or dependence in the patients of Adult Mental Health and Addictions Services in eastern Dorset. J Mental Health 10:175-188
97. Wang PS, Lane M, Olfson M, Pincus HA, Wells KB, Kessler RC (2005) Twelve-month use of mental health services in the United States: Results from the National Comorbidity Survey Replication. Arch Gen Psychiatry 62:629-640
98. Weaver T, Hickman M, Rutter D, Ward J, Stimson G, Renton A (2001) The prevalence and management of co-morbid substance misuse and mental illness: Results of a screening survey in substance misuse and mental health treatment populations. Drug Alcohol Rev 20:407-416
99. Weaver T, Madden P, Charles V, Stimson G, Renton A, Tyrer P, Barnes T, Bench C, Middleton H, Wright N, Paterson S, Shanahan W, Seivewright N, Ford C, COSMIC Collaborative study team (2003) Comorbidity of substance misuse and mental illness in community mental health and substance misuse services. Br J Psychiatry 183:304-313
100. Weaver T, Rutter D, Madden P, Ward J, Stimson G, Renton A (2001) Results of a screening survey for co-morbid substance misuse amongst patients in treatment for psychotic disorders: Prevalence and service needs in an inner London borough. Soc Psychiatry Psychiatr Epidemiol 36:399-406
101. Weaver T, Stimson G, Tyrer P, Barnes T, Renton A (2004) What are the implications for clinical management and service development of prevalent comorbidity in UK mental health and substance misuse treatment populations? Drugs: Education, prevention. and policy 11:329-348
102. Wheatley M (1998) The prevalence and relevance of substance misuse in detained schizophrenic patients. J Forensic Psych 9:114-129
103. Wheatley M (1998) The assessment of substance misuse in the mentally ill detained patient. J Subst Misuse 3:67-72
104. World Health Organization (1973) The International Pilot study of schizophrenia. WHO, Geneva
105. World Health Organization (1992) SCAN: Schedules for Clinical Assessment in Neuropsychiatry. WHO, Geneva
106. World Health Organization (1992) The ICD-10 classification of mental and behavioural disorders: Clinical descriptions and diagnostic guidelines. WHO, Geneva
107. Wright S, Gournay K, Glorney E, Thornicroft G (2000) Dual diagnosis in the suburbs: Prevalence, need, and in-patient service use. Soc Psychiatry Psychiatr Epidemiol 35:297-304
108. Young A (2006) Dual diagnosis and forensic care. Are the needs of service users being met? J Psychiatr Ment Health Nurs 13:117-124